CDK9 and SMYD3 are Diagnostic, Prognostic Markers and Probable Therapeutic Targets in Serous Ovarian Carcinomas.
Saved in:
| Title: | CDK9 and SMYD3 are Diagnostic, Prognostic Markers and Probable Therapeutic Targets in Serous Ovarian Carcinomas. |
|---|---|
| Authors: | Ahmed, Mona Mostafa1 moatafamona90@yahoo.com, Awd, Amr A.2, Elwan, Amira3, Elsayed, Dalia Hamouda4, Hanafy, Sabah Mohamed1,5 |
| Source: | Zagazig University Medical Journal. Nov/Dec2023, Vol. 29 Issue 6, p1497-1505. 9p. |
| Database: | Academic Search Ultimate |
| ISSN: | 11101431 |
|---|---|
| DOI: | 10.21608/ZUMJ.2023.216665.2811 |
